Product Information
APIDRA 100 UNIT/ML VIAL is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $8.1617 per ML under NDC 00088250033. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
100 [iU]/mL
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00088250033
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
INSULIN GLULISINEApproval Type
Biologic (BLA)
FDA Application
BLA021629On Market Since
2/24/2009
Pharmacological Classes
Price Statistics
The NADAC for APIDRA 100 UNIT/ML VIAL has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 39.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.1617 per ML |
|---|---|
| All-time high | $27.2795 (Oct 16, 2019) |
| All-time low | $8.1617 (Jun 17, 2026) |
| 52-week high | $8.1767 |
| 52-week low | $8.1617 |
| Median price | $24.5424 |
| Average price | $21.3626 |
| Largest weekly change | -70.0% (Jan 3, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of APIDRA 100 UNIT/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for APIDRA 100 UNIT/ML VIAL, manufactured by Sanofi-Aventis U.S. LLC, is $8.1617 per ML (NDC 00088250033), effective Jun 24, 2026.
How has the price of APIDRA 100 UNIT/ML VIAL changed over time?
Over the history we have for it, the NADAC for APIDRA 100 UNIT/ML VIAL has declined 39.5%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for APIDRA 100 UNIT/ML VIAL?
Since Nov 28, 2013, the NADAC for APIDRA 100 UNIT/ML VIAL has ranged from a low of $8.1617 (Jun 17, 2026) to a high of $27.2795 (Oct 16, 2019), with a median of $24.5424 per ML.
Are there cheaper alternatives to APIDRA 100 UNIT/ML VIAL?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as APIDRA 100 UNIT/ML VIAL, but none are currently priced below it.
Who manufactures APIDRA 100 UNIT/ML VIAL?
APIDRA 100 UNIT/ML VIAL (NDC 00088250033) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification